Screener
Revolution Medicines, Inc. RVMD Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $80,538 | $64,616 |
| Accrued expenses and other current liabilities | 192,451 | 209,340 |
| Operating lease liability, current | 16,610 | 16,468 |
| Total current liabilities | 289,599 | 290,424 |
| Deferred tax liability | 2,353 | 2,353 |
| Operating lease liability, noncurrent | 140,019 | 142,234 |
| Liability related to the sale of future royalties | 280,643 | 268,446 |
| Warrant liability | 34,327 | 18,546 |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s total current liabilities?
- Revolution Medicines, Inc. (RVMD) reported total current liabilities of $289.6M in Q1 2026.
- How has Revolution Medicines, Inc.'s total current liabilities changed year-over-year?
- Revolution Medicines, Inc.'s total current liabilities increased by 82.6% year-over-year, from $158.6M to $289.6M.
- What is the long-term trend for Revolution Medicines, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s total current liabilities has grown at a 43.8% compound annual growth rate (CAGR), from $47.18M to $290.42M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Revolution Medicines, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude